Cumberland Pharmaceuticals Inc. Depreciation and Amortization
Cumberland Pharmaceuticals Inc. (CPIX) reported Depreciation and Amortization of $71.62 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was -$1.20M.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $1.28M, a 23.72% increase year-over-year.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $1.04M, a 30.37% decline year-over-year.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $3.03M, a 171.10% increase year-over-year.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for fiscal 2025 was $4.15M, a 15.45% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for fiscal 2024 was $4.90M, a 0.68% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for fiscal 2023 was $4.94M, a 7.36% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. depreciation, depletion and amortization for fiscal 2022 was $5.33M, a 15.67% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $71.62K 10-Q · filed 2026-08-07 | $1.11M derived: sum of 3 quarters · filed 2026-08-07 | $4.14M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-08 | $2.32M derived: sum of 2 quarters · filed 2026-05-08 | $5.34M derived: sum of 3 quarters · filed 2026-05-08 | $4.39M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $4.07M derived: sum of 2 quarters · filed 2026-03-09 | $3.11M derived: sum of 3 quarters · filed 2026-08-07 | $4.15M 10-K · filed 2026-03-09 | |
| 2025-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.07M derived: sum of 2 quarters · filed 2026-08-07 | $3.10M 10-Q · filed 2025-11-07 | $4.60M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$953.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $77.77K 10-Q · filed 2026-08-07 | $2.07M 10-Q · filed 2025-08-08 | $1.57M derived: sum of 3 quarters · filed 2026-08-07 | $2.69M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.03M 10-Q · filed 2026-05-08 | $2.53M derived: sum of 2 quarters · filed 2026-05-08 | $3.64M derived: sum of 3 quarters · filed 2026-05-08 | $4.78M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.61M derived: sum of 2 quarters · filed 2026-03-09 | $3.75M derived: sum of 3 quarters · filed 2026-03-09 | $4.90M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.26M derived: sum of 2 quarters · filed 2025-11-07 | $3.41M 10-Q · filed 2025-11-07 | $4.64M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.29M 10-Q · filed 2025-08-08 | $3.52M derived: sum of 3 quarters · filed 2025-08-08 | $4.77M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $1.15M 10-Q · filed 2025-05-09 | $2.38M derived: sum of 2 quarters · filed 2025-05-09 | $3.63M derived: sum of 3 quarters · filed 2025-05-09 | $4.83M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.48M derived: sum of 2 quarters · filed 2025-03-07 | $3.68M derived: sum of 3 quarters · filed 2025-03-07 | $4.94M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.45M derived: sum of 2 quarters · filed 2024-11-08 | $3.70M 10-Q · filed 2024-11-08 | $4.21M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.46M 10-Q · filed 2024-08-09 | $2.97M derived: sum of 3 quarters · filed 2024-08-09 | $4.51M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $1.26M 10-Q · filed 2024-05-10 | $1.77M derived: sum of 2 quarters · filed 2024-05-10 | $3.31M derived: sum of 3 quarters · filed 2024-05-10 | $4.93M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $511.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.06M derived: sum of 2 quarters · filed 2024-03-13 | $3.67M derived: sum of 3 quarters · filed 2024-03-13 | $5.33M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.16M derived: sum of 2 quarters · filed 2023-11-13 | $4.82M 10-Q · filed 2023-11-13 | $5.89M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $3.27M 10-Q · filed 2023-08-11 | $4.35M derived: sum of 3 quarters · filed 2023-08-11 | $5.42M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $1.65M 10-Q · filed 2023-05-12 | $2.73M derived: sum of 2 quarters · filed 2023-05-12 | $3.80M derived: sum of 3 quarters · filed 2023-05-12 | $5.03M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $2.15M derived: sum of 2 quarters · filed 2023-03-13 | $3.38M derived: sum of 3 quarters · filed 2023-03-13 | $4.61M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.30M derived: sum of 2 quarters · filed 2022-11-14 | $3.53M 10-Q · filed 2022-11-14 | $4.75M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.46M 10-Q · filed 2022-08-12 | $3.68M derived: sum of 3 quarters · filed 2022-08-12 | $4.87M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $1.23M 10-Q · filed 2022-05-13 | $2.45M derived: sum of 2 quarters · filed 2022-05-13 | $3.64M derived: sum of 3 quarters · filed 2022-05-13 | $4.82M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.41M derived: sum of 2 quarters · filed 2022-03-11 | $3.60M derived: sum of 3 quarters · filed 2022-03-11 | $4.75M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.37M derived: sum of 2 quarters · filed 2021-11-12 | $3.52M 10-Q · filed 2021-11-12 | $4.65M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.33M 10-Q · filed 2021-08-13 | $3.46M derived: sum of 3 quarters · filed 2022-03-11 | $4.56M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | $1.15M 10-Q · filed 2021-05-14 | $2.28M derived: sum of 2 quarters · filed 2022-03-11 | $3.38M derived: sum of 3 quarters · filed 2022-03-11 | $4.48M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.23M derived: sum of 2 quarters · filed 2022-03-11 | $3.33M derived: sum of 3 quarters · filed 2022-03-11 | $4.40M 10-K · filed 2022-03-11 | |
| 2019-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $2.20M derived: sum of 2 quarters · filed 2020-11-13 | $3.28M 10-Q · filed 2020-11-13 | $4.15M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.17M 10-Q · filed 2020-08-14 | $3.05M derived: sum of 3 quarters · filed 2021-03-12 | $3.76M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-03-31 | $1.08M 10-Q · filed 2020-05-22 | $1.95M derived: sum of 2 quarters · filed 2021-03-12 | $2.66M derived: sum of 3 quarters · filed 2021-03-12 | $3.37M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | $874.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.59M derived: sum of 2 quarters · filed 2021-03-12 | $2.29M derived: sum of 3 quarters · filed 2021-03-12 | $2.98M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $713.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $1.42M derived: sum of 2 quarters · filed 2019-11-13 | $2.11M 10-Q · filed 2019-11-13 | $2.78M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-06-30 | $701.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.39M 10-Q · filed 2019-08-14 | $2.07M derived: sum of 3 quarters · filed 2020-12-10 | $2.73M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-03-31 | $692.99K 10-Q · filed 2019-05-15 | $1.37M derived: sum of 2 quarters · filed 2020-12-10 | $2.03M derived: sum of 3 quarters · filed 2020-12-10 | $2.68M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2017-12-31 | $673.56K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $1.33M derived: sum of 2 quarters · filed 2020-12-10 | $1.99M derived: sum of 3 quarters · filed 2020-12-10 | $2.65M 8-K · filed 2020-12-10 | |
| 2017-09-30 | $659.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.31M derived: sum of 2 quarters · filed 2018-11-14 | $1.97M 10-Q · filed 2018-11-14 | $2.59M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | $652.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.31M 10-Q · filed 2018-08-14 | $1.93M derived: sum of 3 quarters · filed 2019-03-12 | $2.54M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | $661.49K 10-Q · filed 2018-05-09 | $1.27M derived: sum of 2 quarters · filed 2019-03-12 | $1.89M derived: sum of 3 quarters · filed 2019-03-12 | $2.48M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2016-12-31 | $611.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.23M derived: sum of 2 quarters · filed 2019-03-12 | $1.81M derived: sum of 3 quarters · filed 2019-03-12 | $2.40M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $613.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.20M derived: sum of 2 quarters · filed 2017-11-08 | $1.79M 10-Q · filed 2017-11-08 | $2.35M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | $589.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.17M 10-Q · filed 2017-08-09 | $1.74M derived: sum of 3 quarters · filed 2018-03-09 | $2.28M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | $582.09K 10-Q · filed 2017-05-15 | $1.15M derived: sum of 2 quarters · filed 2018-03-09 | $1.69M derived: sum of 3 quarters · filed 2018-03-09 | $2.27M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $568.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.10M derived: sum of 2 quarters · filed 2018-03-09 | $1.69M derived: sum of 3 quarters · filed 2018-03-09 | $2.25M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $534.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.12M derived: sum of 2 quarters · filed 2016-11-03 | $1.68M 10-Q · filed 2016-11-03 | $2.28M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $581.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.14M 10-Q · filed 2016-08-05 | $1.75M derived: sum of 3 quarters · filed 2017-03-13 | $2.33M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $561.25K 10-Q · filed 2016-05-13 | $1.17M derived: sum of 2 quarters · filed 2017-03-13 | $1.75M derived: sum of 3 quarters · filed 2017-03-13 | $2.16M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2014-12-31 | $605.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.19M derived: sum of 2 quarters · filed 2017-03-13 | $1.59M derived: sum of 3 quarters · filed 2017-03-13 | $1.99M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $583.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $988.48K derived: sum of 2 quarters · filed 2015-11-06 | $1.38M 10-Q · filed 2015-11-06 | $1.77M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $405.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $800.23K 10-Q · filed 2015-08-07 | $1.19M derived: sum of 3 quarters · filed 2016-03-14 | $1.49M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $395.13K 10-Q · filed 2015-05-15 | $779.96K derived: sum of 2 quarters · filed 2016-03-14 | $1.09M derived: sum of 3 quarters · filed 2016-03-14 | $1.41M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $384.82K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $691.78K derived: sum of 2 quarters · filed 2016-03-14 | $1.01M derived: sum of 3 quarters · filed 2016-03-14 | $1.30M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $306.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $626.50K derived: sum of 2 quarters · filed 2014-11-07 | $917.01K 10-Q · filed 2014-11-07 | $1.15M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-06-30 | $319.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $610.05K 10-Q · filed 2014-08-08 | $847.33K derived: sum of 3 quarters · filed 2015-03-09 | $1.07M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-03-31 | $290.51K 10-Q · filed 2014-05-12 | $527.79K derived: sum of 2 quarters · filed 2015-03-09 | $750.96K derived: sum of 3 quarters · filed 2015-03-09 | $974.89K derived: sum of 4 quarters · filed 2015-03-09 | |
| 2012-12-31 | $237.28K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $460.45K derived: sum of 2 quarters · filed 2015-03-09 | $684.39K derived: sum of 3 quarters · filed 2015-03-09 | $901.65K 10-K · filed 2015-03-09 | |
| 2012-09-30 | $223.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $447.11K derived: sum of 2 quarters · filed 2013-11-06 | $664.37K 10-Q · filed 2013-11-06 | $903.29K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-06-30 | $223.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $441.20K 10-Q · filed 2013-08-09 | $680.12K derived: sum of 3 quarters · filed 2014-03-11 | $954.30K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-03-31 | $217.26K 10-Q · filed 2013-05-08 | $456.19K derived: sum of 2 quarters · filed 2014-03-11 | $730.37K derived: sum of 3 quarters · filed 2014-03-11 | $995.36K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2011-12-31 | $238.92K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $513.11K derived: sum of 2 quarters · filed 2014-03-11 | $778.10K derived: sum of 3 quarters · filed 2014-03-11 | $1.04M 10-K · filed 2014-03-11 | |
| 2011-09-30 | $274.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $539.18K derived: sum of 2 quarters · filed 2012-11-02 | $801.48K 10-Q · filed 2012-11-02 | $1.06M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $527.30K 10-Q · filed 2012-08-09 | $782.01K derived: sum of 3 quarters · filed 2013-03-12 | $1.04M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | $262.31K 10-Q · filed 2012-05-04 | $517.02K derived: sum of 2 quarters · filed 2013-03-12 | $777.03K derived: sum of 3 quarters · filed 2013-03-12 | ||
| 2010-12-31 | $254.71K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $514.72K derived: sum of 2 quarters · filed 2013-03-12 | $978.40K 10-K · filed 2013-03-12 | ||
| 2010-09-30 | $260.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $723.69K 10-Q · filed 2011-11-07 | |||
| 2010-06-30 | $463.68K 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $816.50K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |